Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Barger

Showing results (51-60 of 54) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 54 results.
Oncotarget|February 14, 2018
Characterization of CDK(5) inhibitor, 20-223 (aka CP668863) for colorectal cancer therapyCaroline M Robb, Smit Kour, Jacob I Contreras, et al.
Oncotarget|July 9, 2020
Correction: Characterization of CDK(5) inhibitor, 20-223 (aka CP668863) for colorectal cancer therapyCaroline M Robb, Smit Kour, Jacob I Contreras, et al.
Molecular Cell|June 13, 2025
The immortality mechanism of TERT promoter mutant cancers is self-reinforcing and reversibleNicholas O Stevers, Somang Kim, Jimmy Bo Yuan, et al.
Cell Reports. Medicine|October 8, 2021
<i>CCNE1</i> copy number is a biomarker for response to combination WEE1-ATR inhibition in ovarian and endometrial cancer modelsHaineng Xu, Erin George, Yasuto Kinose, et al.
Pageof 6

Showing results (51-60 of 54) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 54 results.
Oncotarget|February 14, 2018
Characterization of CDK(5) inhibitor, 20-223 (aka CP668863) for colorectal cancer therapyCaroline M Robb, Smit Kour, Jacob I Contreras, et al.
Oncotarget|July 9, 2020
Correction: Characterization of CDK(5) inhibitor, 20-223 (aka CP668863) for colorectal cancer therapyCaroline M Robb, Smit Kour, Jacob I Contreras, et al.
Molecular Cell|June 13, 2025
The immortality mechanism of TERT promoter mutant cancers is self-reinforcing and reversibleNicholas O Stevers, Somang Kim, Jimmy Bo Yuan, et al.
Cell Reports. Medicine|October 8, 2021
<i>CCNE1</i> copy number is a biomarker for response to combination WEE1-ATR inhibition in ovarian and endometrial cancer modelsHaineng Xu, Erin George, Yasuto Kinose, et al.
Pageof 6